XTRAPHARMA
ActiveSummary
The computed 12-month bankruptcy probability of XTRAPHARMA is 2.1% (moderate). The 2025 annual accounts show equity of €839k and a net result of €143k. Equity is growing by ~15.3% per year across the filed fiscal years. Its solvency ranks better than 44% of 8048 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability77▲+3
Solvency64▲+5
Growth52=
Track record100
Bankruptcy probability, 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 1.55 against 1.44 in 2024; short-term debt: 61.3% and cash: 12.3% of total assets), but 61.3% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
38.7%
Return on assets
6.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
2 d early
2024
117 d late
2023
477 d late
2022
92 d late
2021
194 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
€8.57M
EBIT margin
1.7%
Net result
€143k▲ 70.7%
2024 · €84k
Working capital
€734k▲ 15.2%
2024 · €637k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€8.57M
Operating result€288k-€450k▲ 56.3%€149k▼ 67.0%€126k▼ 15.1%€193k▲ 52.8%
Net result€215k-€343k▲ 59.4%€110k▼ 68.0%€84k▼ 24.0%€143k▲ 70.7%
EBIT margin1.7%
Equity€220k-€563k▲ 156%€673k▲ 19.5%€757k▲ 12.4%€839k▲ 10.9%
Total assets€587k-€1.47M▲ 150%€2.84M▲ 93.3%€2.20M▼ 22.7%€2.17M▼ 1.3%
Debt€367k-€906k▲ 147%€2.17M▲ 139%€1.44M▼ 33.6%€1.33M▼ 7.7%
Working capital€184k-€518k▲ 181%€617k▲ 19.2%€637k▲ 3.3%€734k▲ 15.2%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 53% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.17M
Fixed assets
€106k ▼ 11.8%
Current assets
€2.06M ▼ 0.7%
Equity and liabilities €2.17M
Equity
€839k ▲ 10.9%
Debt
€1.33M ▼ 7.7%
Debt's share of the balance-sheet total falls from 65.5% to 61.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€225k▲
2024 · €151k
Cash flow
€175k▲
2024 · €109k
Current ratio
1.55▲
2024 · 1.44
Quick ratio
1.22▲
2024 · 0.93
Debt to equity
1.58▼
2024 · 1.90
ROE
17.0%▲
2024 · 11.0%
ROA
6.6%▲
2024 · 3.8%
Interest coverage
11.07▲
2024 · 8.85
Debt ≤ 1 year
€1.33M▼
2024 · €1.44M
Income taxes
€38k▲
2024 · €26k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | - | - | €8.57M | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | - | €8.41M | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2k | €5k | €9k | €25k | €32k | ▲ 29.2% |
| Other operating charges640/8 | €795 | €5k | €11k | €7k | €3k | ▼ 58.1% |
| Non-recurring operating charges66A | - | - | - | €376 | - | - |
| Gross operating margin9900 | €290k | €460k | €169k | €159k | €228k | ▲ 43.8% |
| Operating profit (loss)9901 | €288k | €450k | €149k | €126k | €193k | ▲ 52.8% |
| Financial income75/76B | €60 | €2k | €7 | €450 | €8k | ▲ 1,751% |
| Recurring financial income75 | €60 | €2k | €7 | €450 | €8k | ▲ 1,751% |
| Financial charges65/66B | €276 | €638 | €8k | €17k | €20k | ▲ 19.0% |
| Recurring financial charges65 | €276 | €638 | €8k | €17k | €20k | ▲ 19.0% |
| Profit (loss) for the period before taxes9903 | €288k | €451k | €141k | €109k | €181k | ▲ 65.1% |
| Income taxes67/77 | €72k | €108k | €31k | €26k | €38k | ▲ 46.8% |
| Profit (loss) for the period9904 | €215k | €343k | €110k | €84k | €143k | ▲ 70.7% |
| Profit (loss) for the period to be appropriated9905 | €215k | €343k | €110k | €84k | €143k | ▲ 70.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €587k | €1.47M | €2.84M | €2.20M | €2.17M | ▼ 1.3% |
| Fixed assets21/28 | €36k | €46k | €56k | €120k | €106k | ▼ 11.8% |
| Tangible fixed assets22/27 | €29k | €39k | €49k | €113k | €99k | ▼ 12.5% |
| Land and buildings22 | - | - | - | €18k | €14k | ▼ 20.0% |
| Plant, machinery and equipment23 | €20k | €29k | €20k | €15k | €10k | ▼ 31.2% |
| Furniture and vehicles24 | €9k | €10k | €29k | €80k | €74k | ▼ 7.4% |
| Financial fixed assets28 | €7k | €7k | €7k | €7k | €7k | = |
| Current assets29/58 | €550k | €1.42M | €2.78M | €2.08M | €2.06M | ▼ 0.7% |
| Stocks and contracts in progress3 | €38k | €243k | €742k | €737k | €444k | ▼ 39.8% |
| Stocks30/36 | - | €243k | €742k | €737k | €444k | ▼ 39.8% |
| Contracts in progress37 | €38k | - | - | - | - | - |
| Amounts receivable within one year40/41 | €498k | €1.13M | €1.81M | €1.25M | €1.35M | ▲ 7.5% |
| Trade receivables40 | €439k | €949k | €1.56M | €743k | €748k | ▲ 0.7% |
| Other amounts receivable41 | €59k | €178k | €244k | €510k | €598k | ▲ 17.4% |
| Cash at bank and in hand54/58 | €15k | €53k | €227k | €84k | €266k | ▲ 217% |
| Deferred charges and accrued income490/1 | - | - | €6k | €2k | €6k | ▲ 241% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €587k | €1.47M | €2.84M | €2.20M | €2.17M | ▼ 1.3% |
| Equity10/15 | €220k | €563k | €673k | €757k | €839k | ▲ 10.9% |
| Contributions10/11 | €5k | €5k | €5k | €5k | €5k | = |
| Capital10 | - | €5k | - | - | - | - |
| Issued capital100 | - | €30k | - | - | - | - |
| Uncalled capital101 | - | €25k | - | - | - | - |
| Profit (loss) carried forward14 | €215k | €558k | €668k | €752k | €834k | ▲ 11.0% |
| Amounts payable17/49 | €367k | €906k | €2.17M | €1.44M | €1.33M | ▼ 7.7% |
| Amounts payable within one year42/48 | €367k | €906k | €2.17M | €1.44M | €1.33M | ▼ 7.7% |
| Current portion of amounts payable after more than one year42 | - | - | €63k | €50k | €45k | ▼ 9.3% |
| Financial debts43 | - | - | €505k | €395k | €380k | ▼ 3.9% |
| Credit institutions430/8 | - | - | €505k | €395k | €380k | ▼ 3.9% |
| Trade debts44 | €284k | €720k | €1.49M | €864k | €675k | ▼ 21.8% |
| Suppliers440/4 | €284k | €720k | €1.49M | €864k | €675k | ▼ 21.8% |
| Taxes, remuneration and social security45 | €73k | €185k | €104k | €129k | €168k | ▲ 29.4% |
| Taxes450/3 | €73k | €185k | €104k | €129k | €168k | ▲ 29.4% |
| Other amounts payable47/48 | €9k | - | - | - | €60k | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €215k | €343k | €110k | €84k | €143k | ▲ 70.7% |
| + Depreciation and write-downs630 | €2k | €5k | €9k | €25k | €32k | ▲ 29.2% |
| Operating cash flow (approximation) | €217k | €348k | €119k | €109k | €175k | ▲ 61.1% |
| Investment in fixed assets (approximation) | - | €-14k | €-20k | €-88k | €-18k | ▲ 79.4% |
| Change in cash | - | €38k | €174k | €-143k | €182k | ▲ 227% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
25-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 117 days late
20-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 477 days late
2024
31-12
Financial
Weakest financial yearnet €84k ▼24%
Net result drops to €84k, the lowest in the series; recovery starts the following year.
2023
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 92 days late
10-02
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 194 days late
2022
31-12
Financial
Highest result since 2021net €343k ▲59.4%
Operating result €450k, net result €343k, both a record.
31-12
Financial
Equity above €500kEq €563k ▲156%
2 profitable years in a row build equity to €563k.
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2020
Ground area
608 m²
Building footprint
231 m²
Volume, LiDAR
1,904 m³
Parcel 21821B0318/00D002, Brussels · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
XTRAPHARMA
since 20202.362.529.822
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21821B0318/00D002 | Brussels | 608 m² | 1 · 231 m² | 12.4 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Mobio
BE 0599.878.088
Lokeren · Eq €840k
PAMSANTE BENELUX
BE 0748.536.726
Brussel · Eq €841k
TROMP MEDICAL
BE 0644.896.976
Zaventem · Eq €837k
ABW DENTAL
BE 0839.535.988
Andenne · Eq €844k
Swiftpharma
BE 0781.598.284
Genk · Eq €835k
Of 1,902 companies in sector 46460 we hold annual accounts for 1,116. 762 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-07-2020
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
46180Agents specialised in the wholesale of other particular products
Scores and ratios are computed by Checked and are not a credit decision.